NCT06857747 2025-03-04
Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Unknown
Clinical Trials
6 trialsNCT04452370 2021-07-21
Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT02185352 2021-05-07
A-Plus
National Taiwan University Hospital
Phase 2 Unknown
NCT03923179 2019-04-22
Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT00012311 2014-01-06
Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01492556 2013-03-15
Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer
ChineseAMS
Phase 2 Unknown